Invention Grant
- Patent Title: Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
- Patent Title (中): 静脉注射用乙酰水杨酸和茶氨酸的水溶性共晶体
-
Application No.: US12437735Application Date: 2009-05-08
-
Publication No.: US08173625B2Publication Date: 2012-05-08
- Inventor: Harry G. Brittain , Philip V. Felice
- Applicant: Harry G. Brittain , Philip V. Felice
- Applicant Address: US NY Hauppauge
- Assignee: Theaprin Pharmaceuticals Inc.
- Current Assignee: Theaprin Pharmaceuticals Inc.
- Current Assignee Address: US NY Hauppauge
- Agency: Notaro, Michalos & Zaccaria P.C.
- Main IPC: A61K31/60
- IPC: A61K31/60 ; A61K31/12

Abstract:
A water-soluble aspirin-theanine cocrystal composition which includes a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer associated with the quantity of acetylsalicylic acid. The composition may be created by a method including the steps of: (i) providing a quantity of acetylsalicylic acid; (ii) adding a quantity of a theanine enantiomer to the quantity of acetylsalicylic acid to form a mixture comprising the quantity of acetylsalicylic acid and the enantiomer of theanine; (iii) wetting the mixture; and (iv) grinding the mixture for a length of time sufficient to produce a dried crystalline mass. The water-soluble cocrystal composition is suitable for intravenous administration, preferably to humans.
Public/Granted literature
- US20100286099A1 INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE Public/Granted day:2010-11-11
Information query